US scientists develop new hormones to benefit diabetic patients

It is understood that researchers who study ELISA kits have been looking for a treatment that can replace the simple injection of insulin, and this new hormone called betatrophin can promote the production of human insulin. Researchers at Harvard University said: "Typically, patients with type 2 diabetes need to be injected with insulin three times a day, and the betatrophin hormone can reduce the frequency of injections to once a week or monthly. In the best case, only one injection per year is needed. can."

In the case of ELISA kits, patients with type 2 diabetes need to be injected with insulin three times a day.

In the test of experimental mice, the betatrophin hormone can increase the number of insulin β cells in its body by more than 30 times. The researchers believe that this hormone will greatly improve the treatment status of "type 2 diabetes".

"Type 2 diabetes" is a common type of diabetes. The main symptom of the ELISA kit is that there is not enough insulin in the pancreatic cells of the patient for energy conversion. Early patients need to strictly control diet and maintain exercise. If the condition worsens, they need to be regular Taking or injecting insulin. Currently, one in every 20 Britons is a diabetic, and the proportion of "type 2 diabetes" in all patients is as high as 90%.

Dinosaur Island Toys

Dinosaur Island Toys

Shantou Chenghai Sweet Baby Toys Firm , https://www.sweetbabytoys.com